Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Kura Oncology, Inc.
Kura Oncology, Inc.
Ossium Health, Inc.
EMD Serono
Hoffmann-La Roche
Merck Sharp & Dohme LLC
Array BioPharma
Array BioPharma
Eli Lilly and Company
Nohla Therapeutics, Inc.
Altor BioScience
Proacta, Incorporated